A

ALK-Abelló
ALK B

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
DKK32.45B
EV
DKK33.05B
Shares Outstanding
221.39M
Beta
0.60

Wall Street View

Analyst Rating
BUY
Analyst Target Price
DKK181.25
P/E 2025E
27.94x
P/Revenue 2025E
5.26x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About ALK-Abelló A/S

gainify

A

ALK-Abelló A/S

ALK B

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and...

Sector

Healthcare

Industry

Biotechnology

CEO

Halling, Peter

Employees

2,753

IPO Date

2000-03-10

Headquarters

BOege AllE 6-8, Horsholm, Capital Region of Denmark, 2970, Denmark

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved